Answers are grounded in this paper and cite their sources.
Prospective study reports high remission and MRD negativity rates in pediatric ALL in India, suggesting effective local treatments.
Acute lymphoblastic leukemia (ALL) accounts for more than 50% of pediatric acute leukemias. In developing countries such as India, pediatric ALL is treated using a variety of protocols, including those adapted from Western regimens as well as indigenous Indian protocols. However, data on minimal residual disease (MRD) outcomes from developing countries remain limited. To report the demographic characteristics and induction outcomes, including MRD outcomes, of pediatric ALL patients treated with the Children Cancer Group 1961 protocol at a single center in Southern India. This is a prospective, single-center observational study done at a trust hospital in South India, approved by the institutional ethics committee. The objective of the study was to study the induction outcomes of pediatric ALL. This study included newly diagnosed ALL patients under the age of 18 treated at our center between December 2018 and November 2019. The primary endpoint was complete remission (CR) rates at the end of induction, and the secondary endpoints were MRD negativity at the end of induction, toxicity, and induction mortality. Statistics were done using IBM SPSS 21. The study included 33 patients, of whom 2 were excluded as they did not take treatment, and analysis was done in 31 patients. The median age was 6 years. Males constituted 73%. B cell type was 88%. Central nervous system involvement was seen in 6%. Febrile neutropenia was seen in 68%. Induction mortality was seen in 6.5% (n = 2) due to septic shock. The median duration of induction was 36 days. CR was achieved in 93.5% (n = 29). MRD negativity rate was 81% (n = 25). None of the baseline factors influenced the MRD rates significantly. This is one of the very few prospective studies that have reported the MRD rates at induction from India. Toxicity data has been captured accurately and has been reported. The outcomes of induction mortality (6.5%), CR rates (93.5%), and MRD negativity rates (81%) are comparable with various other retrospective data and also from Western centers.
No takes yet. Share an insight, caveat, or question.
Samudi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: